Lagatar24 Desk
New Delhi, April 26: The Drugs Controller General of India (DCGI) has granted emergency use approval to ZycovD (Zydus Cadila vaccine) for children aged 12 and up, as well as emergency use authorisation to Corbevax for children aged 5 to 12.
Earlier today, DCGI gave the restricted emergency use authorisation to Bharat Biotech’s Covaxin for children between the age of 6-12 years. It also approved restricted use in emergency situation for Biological E’s Covid-19 vaccine Corbevax for children of 5 to 12 years age group.
“India’s fight against Covid more stronger! @CDSCO_INDIA_INF has approved Covaxin for 6 to 12 years of age group, Corbevax for 5 to 12 years age group of children and two doses ZyCoV-D for above 12 years of age group for Restricted Use in Emergency Situations,” Union Health Minister Mansukh Mandaviya tweeted in Hindi.
This development follows the Subject Expert Committee’s discussion of suggestions for the limited emergency use of Covaxin in children aged 2 to 12. The SEC, however, has recommended limited emergency use of Biological E’s Covid-19 vaccine, Corbevax, in children aged 5 to 12 years, following a meeting on Thursday.